Safety Evaluation of Intranasal Use of DSM 32444 Postbiotic in Humans

NCT05984004 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhino Sinusitis

Interventions

DRUG: 0.9% NaCl isotonic saline solution
COMBINATION_PRODUCT: Bacillus subtilis DSM32444, inactivated

Sponsor

Huro Biotech Joint Stock Company

Collaborators

[object Object]